Champions Oncology, Inc. CSBR
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.17M | -1.21M | -2.37M | 2.46M | 2.92M |
| Total Depreciation and Amortization | 1.33M | 1.38M | 1.45M | 1.51M | 1.55M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.31M | 2.78M | 2.60M | 2.25M | 1.70M |
| Change in Net Operating Assets | -9.04M | -7.42M | 2.72M | 4.00K | 1.51M |
| Cash from Operations | -5.56M | -4.47M | 4.39M | 6.22M | 7.68M |
| Capital Expenditure | -573.00K | -564.00K | -578.00K | -583.00K | -435.00K |
| Sale of Property, Plant, and Equipment | 24.00K | 24.00K | 23.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -549.00K | -540.00K | -555.00K | -583.00K | -435.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -116.00K | -135.00K | -154.00K | -153.00K | -151.00K |
| Issuance of Common Stock | 262.00K | 234.00K | 240.00K | 275.00K | 344.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 146.00K | 99.00K | 86.00K | 122.00K | 193.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.97M | -4.91M | 3.93M | 5.76M | 7.43M |